COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 587: Articles 5861-5870  | Next

On the role of different age groups in propagating Omicron epidemics in France
Goldstein, E.
10.1101/2022.12.22.22283867 — Posted: 2022-12-23
Calculation and meaning of "excess mortality": A comparison of Covid- and pre-Covid mortality data in 31 Eurostat countries from 1965 to 2021.
Gill, B., Kehler, T., Schneider, M.
10.1101/2022.12.22.22283850 — Posted: 2022-12-23
Monkeypox Post COVID19: Knowledge, Worrying, and Vaccine Adoption of the Arabic General Population
Swed, S., Bohsas, H., Alibrahim, H., Rakab, A., Hafez, W., Sawaf, B., Amir Rais, M., Sallam Motawei, A., Aljabali, A., shoib, S., Atef Ismail Ahmed Ibrahim, I., Hussein Ahmad Almashaqbeh, S., Ahmed Qaid Shaddad, E., AlShaqsi, M., abdelrahman, A., fathey, S., Hurlemann, R., Elsayed, M., Padhi, B. K., Sah, R.
10.1101/2022.12.20.22283750 — Posted: 2022-12-23
Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
Kallolimath, S., Palt, R., Föderl-Höbenreich, E., Sun, L., Chen, Q., Pruckner, F., Eidenberger, L., Strasser, R., Zatloukal, K., Steinkellner, H.
10.1101/2022.12.22.521646 — Posted: 2022-12-23
Common dandelion (Taraxacum officinale) leaf extract efficiently inhibits SARS-CoV-2 Omicron infection in vitro
Tran, H. T. T., Gigl, M., Dawid, C., Lamy, E.
10.1101/2022.12.22.521558 — Posted: 2022-12-22
Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
Guseman, A. J., Rennick, L. J., Nambulli, S., Roy, C. N., Martinez, D., Yang, D. T., Bhinderwhala, F., Vergara, S., Baric, R. S., Ambrose, Z., Duprex, W. P., Gronenborn, A. M.
10.1101/2022.12.22.521642 — Posted: 2022-12-22
Human coronaviruses activate and hijack the proteostasis guardian HSF1 to enhance viral replication
Pauciullo, S., Riccio, A., Rossi, A., Santopolo, S., Piacentini, S., Santoro, M. G.
10.1101/2022.12.22.519205 — Posted: 2022-12-22
T-cell cellular stress and reticulocyte signatures, but not loss of naive T lymphocytes, characterize severe COVID-19 in older adults
Jergovic, M., Watanabe, M., Bhat, R., Coplen, C. P., Sonar, S. A., Wong, R., Castaneda, Y., Davidson, L., Kala, M., Wilson, R. C., Twigg, H. L., Knox, K., Erickson, H. E., Weinkauf, C. C., Bime, C., Bixby, B. A., Parthasarathy, S., Mosier, J. M., LaFleur, B. J., Bhattacharya, D., Nikolich, J. Z.
10.1101/2022.12.21.521463 — Posted: 2022-12-22
SARS-CoV-2 infections in migrants and the role of household overcrowding: A causal mediation analysis of Virus Watch data
Boukari, Y., Beale, S., Nguyen, V., Fong, W. L. E., Burns, R., Yavlinsky, A., Hoskins, S. J., Lewis, K. M., Geismar, C., Navaratnam, A. M. D., Braithwaite, I., Byrne, T. E., Oskrochi, Y., Tweed, S., Kovar, J., Patel, P., Hayward, A., Aldridge, R. W.
10.1101/2022.12.21.22283794 — Posted: 2022-12-22
Quantitative multi-organ proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation
Schweizer, L., Schaller, T., Zwiebel, M., Karayel, O., Mueller-Reif, J. B., Zeng, W.-F., Dintner, S., Hirschbuehl, K., Maerkl, B., Claus, R., Mann, M.
10.1101/2022.12.21.22283785 — Posted: 2022-12-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).